Jun 20, 2017

JICA supports SPMC to increase production of generic drugs

A Japanese Contractor and the State Pharmaceuticals Manufacturing Corporation (SPMC) entered into an agreement to increase the production capacity of generic drugs and eliminate the dependency on imports.

Secretary to the Ministry of Health Anura Jayawickrama signed the contract for the Refurbishment and Construction of the strengthening of the State Pharmaceuticals Manufacturing Corporation (SPMC) with a Japanese contractor under the JICA Project for the Improvement of Basic Social Services Targeting Emerging Regions.

SPMC is the largest government pharmaceutical manufacturer in Sri Lanka. In 1987 the Japanese government extended Grant Aid cooperation to the SPMC for the establishment of the organization. Since then SPMC has been manufacturing a broad range of branded generic products to cater the needs of the country.

However, due to the changing disease patterns and increase burden in the Non Communicable Diseases, it is necessary to increase national production of generic drugs to ensure the steady supply of essential drugs which are mostly being imported at present.

Such importations have caused occasional shortages of drugs at hospitals and the project aims to reduce the current dependency on imports to manage the current needs.

With the proposed expansion it is planned to procure and install the equipment for the new production line and related activities in order to increase the production capacity to 3,200 million tablets/capsules.